Compare
Nutra Pharma Corp vs China Foods Holdings Ltd. vs Adia Nutrition, Inc. vs TFA Therapeutics, Inc.
| Latest fiscal year | Nutra Pharma Corp NPHC | China Foods Holdings Ltd. CFOO | Adia Nutrition, Inc. ADIA | TFA Therapeutics, Inc. RAJAF |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $257.6K | $327.9K | $700.5K | $1.25M |
| Revenue growth (YoY) | +4.6% | +40.5% | n/m | -0.6% |
| Gross margin | 76.3% | 9.1% | 27.4% | 61.1% |
| Operating margin | -567.7% | -121.7% | -52.3% | -11.3% |
| Net margin | -794.8% | -121.6% | -56.5% | -12.4% |
| Net income | -$2.05M | -$398.7K | -$395.5K | -$154.8K |
| EPS (Diluted) | $0.00 | -$0.02 | $0.00 | $0.00 |
| Operating cash flow | -$1.16M | -$389.3K | -$179.2K | -$35.8K |
| Free cash flow | -$1.19M | n/a | -$192.4K | n/a |
| Cash & equivalents | $12.2K | $9.9K | $79.4K | $3.2K |
| Total assets | $584.6K | $212.9K | $594.8K | $4.66M |
| Total liabilities | $17.41M | $1.49M | $852.5K | $5.19M |
| Shareholders' equity | -$16.83M | -$1.28M | -$257.7K | -$534.6K |
| Return on year-end equity | n/a | n/a | n/a | n/a |
| Shares outstanding | 7.10B | 20.25M | n/a | 111.12M |
Revenue, most recent five fiscal years
| Fiscal year | Nutra Pharma Corp | China Foods Holdings Ltd. | Adia Nutrition, Inc. | TFA Therapeutics, Inc. |
|---|---|---|---|---|
| Latest | $257.6K Ended 2025-12-31 | $327.9K Ended 2025-12-31 | $700.5K Ended 2025-12-31 | $1.25M Ended 2025-12-31 |
| 1 year earlier | $246.3K Ended 2024-12-31 | $233.3K Ended 2024-12-31 | $6.4K Ended 2024-12-31 | $1.25M Ended 2024-12-31 |
| 2 years earlier | $205.6K Ended 2023-12-31 | $158.5K Ended 2023-12-31 | n/a | $882.5K Ended 2023-12-31 |
| 3 years earlier | $145.8K Ended 2022-12-31 | $354.1K Ended 2022-12-31 | n/a | $53.3K Ended 2022-12-31 |
| 4 years earlier | $97.7K Ended 2021-12-31 | $361.1K Ended 2021-12-31 | n/a | $879.3K Ended 2021-12-31 |